Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein

被引:50
作者
Jaworska, Joanna
Gravel, Annie
Fink, Karin
Grandvaux, Nathalie
Flamand, Louis
机构
[1] CHUQ, Rheumatol & Immunol Res Ctr, Res Ctr, Virol Lab, Quebec City, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada
[3] Univ Montreal, Fac Med, Dept Biochem, Montreal, PQ H3C 3J7, Canada
[4] Hop St Luc, CHUM, Res Ctr, Montreal, PQ H2X 1P1, Canada
关键词
D O I
10.1128/JVI.02443-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human herpesviruses (HHV) are stealth pathogens possessing several decoy or immune system evasion mechanisms favoring their persistence within the infected host. Of these viruses, HHV-6 is among the most successful human parasites, establishing lifelong infections in nearly 100% of individuals around the world. To better understand this host-pathogen relationship, we determined whether HHV-6 could interfere with the development of the innate antiviral response by affecting interferon (IFN) biosynthesis. Using inducible cell lines and transient transfection assays, we have identified the immediate-early 1 (IE1) protein as a potent inhibitor of IFN-beta gene expression. IE1 proteins from both HHV-6 variants were capable of suppressing IFN-P gene induction. IE1 prevents IFN-beta gene expression triggered by Sendai virus infection, double-stranded RNA (dsRNA) and dsDNA transfection, or the ectopic expression of IFN-beta gene activators such as retinoic inducible gene I protein, mitochondrial antiviral signaling protein, TBK-1, I kappa B kinase epsilon (IKK epsilon), and IFN regulatory factor 3 (IRF3). While the stability of IFN-beta mRNA is not affected, IE1-expressing cells have reduced levels of dimerized IRF3 and nucleus-translocated IRF3 in response to activation by TBK-1 or IKK epsilon. Using nuclear extracts and gel shift experiments, we could demonstrate that in the presence of IE1, IRF3 does not bind efficiently to the IFN-beta promoter sequence. Overall, these results indicate that the IE1 protein of HHV-6, one of the first viral proteins synthesized upon viral entry, is a potent suppressor of IFN-P gene induction and likely contributes to favor the establishment of and successful infection of cells with this virus.
引用
收藏
页码:5737 / 5748
页数:12
相关论文
共 83 条
[1]   Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response [J].
Abate, DA ;
Watanabe, S ;
Mocarski, ES .
JOURNAL OF VIROLOGY, 2004, 78 (20) :10995-11006
[2]  
Akira S, 2006, CURR TOP MICROBIOL, V311, P1
[3]  
Arao Y, 1997, J MED VIROL, V53, P105
[4]   FATAL FULMINANT-HEPATITIS IN AN INFANT WITH HUMAN HERPESVIRUS-6 INFECTION [J].
ASANO, Y ;
YOSHIKAWA, T ;
SUGA, S ;
YAZAKI, T ;
KONDO, K ;
YAMANISHI, K .
LANCET, 1990, 335 (8693) :862-863
[5]   The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 [J].
Basler, CF ;
Mikulasova, A ;
Martinez-Sobrido, L ;
Paragas, J ;
Mühlberger, E ;
Bray, M ;
Klenk, HD ;
Palese, P ;
García-Sastre, A .
JOURNAL OF VIROLOGY, 2003, 77 (14) :7945-7956
[6]   Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3 [J].
Bossert, B ;
Marozin, S ;
Conzelmann, KK .
JOURNAL OF VIROLOGY, 2003, 77 (16) :8661-8668
[7]   Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells [J].
Browne, EP ;
Shenk, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11439-11444
[8]  
Burysek L, 1999, J VIROL, V73, P7334
[9]   INTERSTITIAL PNEUMONITIS ASSOCIATED WITH HUMAN HERPESVIRUS-6 INFECTION AFTER MARROW TRANSPLANTATION [J].
CARRIGAN, DR ;
DROBYSKI, WR ;
RUSSLER, SK ;
TAPPER, MA ;
KNOX, KK ;
ASH, RC .
LANCET, 1991, 338 (8760) :147-149
[10]   Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures [J].
Caruso, A ;
Favilli, F ;
Rotola, A ;
Comar, M ;
Horejsh, D ;
Alessandri, G ;
Grassi, M ;
Di Luca, D ;
Fiorentini, S .
JOURNAL OF MEDICAL VIROLOGY, 2003, 70 (03) :451-458